Trice Medical received FDA 510(k) clearance to market mi-eye 2, a disposable needle with integrated camera to support diagnosis of joint injury.
The next-generation iteration of mi-eye technology is designed for use in diagnostic and operative arthroscopic and endoscopic procedures to illuminate an interior cavity through a natural or surgical opening. mi-eye 2 also allows injection or aspiration under direct visualization.
Platform enhancements include improved resolution, field of view, depth of field and overall visualization.
Trice Medical received FDA 510(k) clearance to market mi-eye 2, a disposable needle with integrated camera to support diagnosis of joint injury.
The next-generation iteration of mi-eye technology is designed for use in diagnostic and operative arthroscopic and endoscopic procedures to illuminate an interior cavity through a natural or surgical...
Trice Medical received FDA 510(k) clearance to market mi-eye 2, a disposable needle with integrated camera to support diagnosis of joint injury.
The next-generation iteration of mi-eye technology is designed for use in diagnostic and operative arthroscopic and endoscopic procedures to illuminate an interior cavity through a natural or surgical opening. mi-eye 2 also allows injection or aspiration under direct visualization.
Platform enhancements include improved resolution, field of view, depth of field and overall visualization.
Copy to clipboard 
